Elizabeth Walsh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elizabeth Walsh has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Anna Mazzucco
Office of the Director, NIH Bethesda Maryland USA
1 shared publicationBryanna Schwartz
National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) Bethesda Maryland USA
1 shared publicationCharlene Schramm
National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) Bethesda Maryland USA
1 shared publicationErika Tarver
National Institute on Aging (NIA), NIH Bethesda Maryland USA
1 shared publicationGail Pearson
National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) Bethesda Maryland USA
1 shared publicationHuiqing Li
National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) Bethesda Maryland USA
1 shared publication
Latest Publications
- 10 January 2024
- Published by Wiley in American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Vol. 196 (1) , e32081
The National Institutes of Health INvestigation of Co‐occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project: Accelerating research discoveries for people with Down syndrome across the lifespan
The National Institutes of Health (NIH) has a long‐standing history of support for research in Down syndrome (DS). In response to a 2018 congressional directive for a trans‐NIH initiative to address medical issues in DS, NIH launched the INCLUDE Project (INvestigation of Co‐occurring conditions across the Lifespan to Understand Down syndromE). Reflecting the three INCLUDE components of basic science research, cohort development, and clinical trials, the Project has published funding opportunities to address conditions such as immune disorders and Alzheimer's disease. Due to a steady expansion in dedicated funding over its first 5 years, INCLUDE has invested $258 M in over 250 new research projects. INCLUDE also supports training initiatives to expand the number and diversity of investigators studying DS. NIH has funded an INCLUDE Data Coordinating Center that is collecting de‐identified clinical information and multi‐omics data from research participants for broad data sharing and secondary analyses. Through the DS‐Connect® registry, INCLUDE investigators can access recruitment support. The INCLUDE Research Plan articulates research goals for the program, with an emphasis on diversity of research participants and investigators. Finally, a new Cohort Development Program is poised to increase the impact of the INCLUDE Project by recruiting a large DS cohort across the lifespan.
- 10 January 2024
- Published by Wiley in American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Vol. 196 (1) , e32081
The National Institutes of Health INvestigation of Co‐occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project: Accelerating research discoveries for people with Down syndrome across the lifespan
The National Institutes of Health (NIH) has a long‐standing history of support for research in Down syndrome (DS). In response to a 2018 congressional directive for a trans‐NIH initiative to address medical issues in DS, NIH launched the INCLUDE Project (INvestigation of Co‐occurring conditions across the Lifespan to Understand Down syndromE). Reflecting the three INCLUDE components of basic science research, cohort development, and clinical trials, the Project has published funding opportunities to address conditions such as immune disorders and Alzheimer's disease. Due to a steady expansion in dedicated funding over its first 5 years, INCLUDE has invested $258 M in over 250 new research projects. INCLUDE also supports training initiatives to expand the number and diversity of investigators studying DS. NIH has funded an INCLUDE Data Coordinating Center that is collecting de‐identified clinical information and multi‐omics data from research participants for broad data sharing and secondary analyses. Through the DS‐Connect® registry, INCLUDE investigators can access recruitment support. The INCLUDE Research Plan articulates research goals for the program, with an emphasis on diversity of research participants and investigators. Finally, a new Cohort Development Program is poised to increase the impact of the INCLUDE Project by recruiting a large DS cohort across the lifespan.
- 16 November 2021
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 51 (1) , 1-4
Diagnostic accuracy of ultrasonography‐guided core needle biopsy of parotid gland neoplasms: A large, single‐institution experience in United Kingdom
Salivary gland tumours present a pleomorphic and complex morphology and, apart from the most common neoplasms with well‐established histopathological criteria, may create diagnostic difficulty for histopathologists. The majority of salivary gland tumours occur in the parotid gland and the use of ultrasound guided parotid biopsy (US‐PB) has increased. US‐PB in contrast with fine needle aspiration (FNA), which is an easy and relatively painless technique, is performed under local anaesthesia, usually by radiologists. US‐PB offers some advantages over the FNA such as tumour grading and the possibility of performing immunohistochemistry. We report our experience of the diagnostic value of US‐PB in a large, referral centre in the United Kingdom.
- 16 November 2021
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 51 (1) , 1-4
Diagnostic accuracy of ultrasonography‐guided core needle biopsy of parotid gland neoplasms: A large, single‐institution experience in United Kingdom
Salivary gland tumours present a pleomorphic and complex morphology and, apart from the most common neoplasms with well‐established histopathological criteria, may create diagnostic difficulty for histopathologists. The majority of salivary gland tumours occur in the parotid gland and the use of ultrasound guided parotid biopsy (US‐PB) has increased. US‐PB in contrast with fine needle aspiration (FNA), which is an easy and relatively painless technique, is performed under local anaesthesia, usually by radiologists. US‐PB offers some advantages over the FNA such as tumour grading and the possibility of performing immunohistochemistry. We report our experience of the diagnostic value of US‐PB in a large, referral centre in the United Kingdom.